K C Rice|J M Cook - JoVE Visualize

Showing results (191-200 of 475) with videos related to

Pageof 48

Sort By:

Peptides|November 1, 1993

Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sitesQ Ni, H Xu, J S Partilla, et al.

Canadian Journal of Physiology and Pharmacology|February 1, 1989

Characterization of the effects of AHN 086, an irreversible ligand of "peripheral" benzodiazepine receptors, on contraction in guinea-pig atrial and ileal longitudinal smooth muscleG T Bolger, A H Newman, K C Rice, et al.

Molecular Pharmacology|March 1, 1985

A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.

British Journal of Pharmacology|November 26, 2015

Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4X Wang, Y Zhang, Y Peng, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 1991

Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studiesY Sawada, R Kawai, M McManaway, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999

Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeysM R Brandt, S S Negus, N K Mello, et al.

Journal of Medicinal Chemistry|August 20, 1993

Synthesis and binding properties of MK-801 isothiocyanates; (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding siteJ T Linders, J A Monn, M V Mattson, et al.

Neuropeptides|June 1, 1985

Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.

Journal of Addictive Behaviors, Therapy & Rehabilitation|October 31, 2017

Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in PrimatesS G Lindell, M L Schwandt, S J Suomi, et al.

The Journal of Pharmacy and Pharmacology|December 1, 1989

Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.

Pageof 48

Showing results (191-200 of 475) with videos related to

Sort By:

Pageof 48

Peptides|November 1, 1993

Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sitesQ Ni, H Xu, J S Partilla, et al.

Canadian Journal of Physiology and Pharmacology|February 1, 1989

Characterization of the effects of AHN 086, an irreversible ligand of "peripheral" benzodiazepine receptors, on contraction in guinea-pig atrial and ileal longitudinal smooth muscleG T Bolger, A H Newman, K C Rice, et al.

Molecular Pharmacology|March 1, 1985

A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.

British Journal of Pharmacology|November 26, 2015

Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4X Wang, Y Zhang, Y Peng, et al.

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 1, 1991

Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studiesY Sawada, R Kawai, M McManaway, et al.

The Journal of Pharmacology and Experimental Therapeutics|August 24, 1999

Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeysM R Brandt, S S Negus, N K Mello, et al.

Journal of Medicinal Chemistry|August 20, 1993

Synthesis and binding properties of MK-801 isothiocyanates; (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten- 5,10-imine hydrochloride: a new, potent and selective electrophilic affinity ligand for the NMDA receptor-coupled phencyclidine binding siteJ T Linders, J A Monn, M V Mattson, et al.

Neuropeptides|June 1, 1985

Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.

Journal of Addictive Behaviors, Therapy & Rehabilitation|October 31, 2017

Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in PrimatesS G Lindell, M L Schwandt, S J Suomi, et al.

The Journal of Pharmacy and Pharmacology|December 1, 1989

Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.

Pageof 48